itriglumide
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Cholecystokinin B receptorANTAGONIST
CCKBR antagonist
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(C)c(NC(=O)C[C@H](CC(=O)O)c2cccc3ccccc23)c(C(=O)N2CCC3(CCCC3)CC2)c1- Mol. weight
- 526.68 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1256717 ↗
Also known as
- beta-(2-((2-(azaspiro(4.5)dec-8-ylcarbonyl)-4,6-dimethylphenyl)amino)-2-oxoethyl)-(r)-1-naphthalenepropanoic acid
- cr2945
- cr 2945
- cr-2945
- cr-2945
- cr-2945
- itriglumide
- itriglumide